Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee
Standard
Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee. / Algwaiz, Ghada; Aljurf, Mahmoud; Koh, Mickey; Horowitz, Mary M; Ljungman, Per; Weisdorf, Daniel; Saber, Wael; Kodera, Yoshihisa; Szer, Jeff; Jawdat, Dunia; Wood, William A; Brazauskas, Ruta; Lehmann, Leslie; Pasquini, Marcelo C; Seber, Adriana; Lu, Pei Hua; Atsuta, Yoshiko; Riches, Marcie; Perales, Miguel-Angel; Worel, Nina; Okamoto, Shinichiro; Srivastava, Alok; Chemaly, Roy F; Cordonnier, Catherine; Dandoy, Christopher E; Wingard, John R; Kharfan-Dabaja, Mohamed A; Hamadani, Mehdi; Majhail, Navneet S; Waghmare, Alpana A; Chao, Nelson; Kröger, Nicolaus; Shaw, Bronwen; Mohty, Mohamad; Niederwieser, Dietger; Greinix, Hildegard; Hashmi, Shahrukh K; WBMT and the CIBMTR Health Services and International Studies Committee.
in: BIOL BLOOD MARROW TR, Jahrgang 26, Nr. 12, 12.2020, S. 2181-2189.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee
AU - Algwaiz, Ghada
AU - Aljurf, Mahmoud
AU - Koh, Mickey
AU - Horowitz, Mary M
AU - Ljungman, Per
AU - Weisdorf, Daniel
AU - Saber, Wael
AU - Kodera, Yoshihisa
AU - Szer, Jeff
AU - Jawdat, Dunia
AU - Wood, William A
AU - Brazauskas, Ruta
AU - Lehmann, Leslie
AU - Pasquini, Marcelo C
AU - Seber, Adriana
AU - Lu, Pei Hua
AU - Atsuta, Yoshiko
AU - Riches, Marcie
AU - Perales, Miguel-Angel
AU - Worel, Nina
AU - Okamoto, Shinichiro
AU - Srivastava, Alok
AU - Chemaly, Roy F
AU - Cordonnier, Catherine
AU - Dandoy, Christopher E
AU - Wingard, John R
AU - Kharfan-Dabaja, Mohamed A
AU - Hamadani, Mehdi
AU - Majhail, Navneet S
AU - Waghmare, Alpana A
AU - Chao, Nelson
AU - Kröger, Nicolaus
AU - Shaw, Bronwen
AU - Mohty, Mohamad
AU - Niederwieser, Dietger
AU - Greinix, Hildegard
AU - Hashmi, Shahrukh K
AU - WBMT and the CIBMTR Health Services and International Studies Committee
N1 - Copyright © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.
PY - 2020/12
Y1 - 2020/12
N2 - The current COVID-19 pandemic, caused by SARS-CoV-2, has impacted many facets of hematopoietic cell transplantation (HCT) in both developed and developing countries. Realizing the challenges as a result of this pandemic affecting the daily practice of the HCT centers and the recognition of the variability in practice worldwide, the Worldwide Network for Blood and Marrow Transplantation (WBMT) and the Center for International Blood and Marrow Transplant Research's (CIBMTR) Health Services and International Studies Committee have jointly produced an expert opinion statement as a general guide to deal with certain aspects of HCT, including diagnostics for SARS-CoV-2 in HCT recipient, pre- and post-HCT management, donor issues, medical tourism, and facilities management. During these crucial times, which may last for months or years, the HCT community must reorganize to proceed with transplantation activity in those patients who urgently require it, albeit with extreme caution. This shared knowledge may be of value to the HCT community in the absence of high-quality evidence-based medicine. © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
AB - The current COVID-19 pandemic, caused by SARS-CoV-2, has impacted many facets of hematopoietic cell transplantation (HCT) in both developed and developing countries. Realizing the challenges as a result of this pandemic affecting the daily practice of the HCT centers and the recognition of the variability in practice worldwide, the Worldwide Network for Blood and Marrow Transplantation (WBMT) and the Center for International Blood and Marrow Transplant Research's (CIBMTR) Health Services and International Studies Committee have jointly produced an expert opinion statement as a general guide to deal with certain aspects of HCT, including diagnostics for SARS-CoV-2 in HCT recipient, pre- and post-HCT management, donor issues, medical tourism, and facilities management. During these crucial times, which may last for months or years, the HCT community must reorganize to proceed with transplantation activity in those patients who urgently require it, albeit with extreme caution. This shared knowledge may be of value to the HCT community in the absence of high-quality evidence-based medicine. © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
KW - Bone Marrow Transplantation
KW - COVID-19/diagnosis
KW - Hematopoietic Stem Cell Transplantation
KW - Humans
KW - SARS-CoV-2
U2 - 10.1016/j.bbmt.2020.07.021
DO - 10.1016/j.bbmt.2020.07.021
M3 - SCORING: Journal article
C2 - 32717432
VL - 26
SP - 2181
EP - 2189
JO - BIOL BLOOD MARROW TR
JF - BIOL BLOOD MARROW TR
SN - 1083-8791
IS - 12
ER -